![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](fb2127contents.gif)
Acta Cryst. (2009). E65, o432-o433 [ doi:10.1107/S1600536809003365 ]
Abstract: The title compound, C19H19N3O7, is a thymidine derivative and serves as an intermediate in the synthesis of a 99mTc radiolabeled nucleoside analog. Intermolecular O-H
O hydrogen bonding is observed between the hydroxy functionalities of the ribose unit themselves as well as between a hydroxy group and an O atom of the phthalimide group of an adjacent molecule. The molecules are stacked on top of each other in the direction of the a axis. The crystal packing is further stabilized by weak intra- and intermolecular C-H
O hydrogen bonds. The absolute configuration of the compound is known from the synthesis.
Online 31 January 2009
Copyright © International Union of Crystallography
IUCr Webmaster